Selling a Family Business for 32 Million Could Trigger a 740000 Tax Bill Without Proactive Planning New York Fed Study Reveals LowerIncome Households Bear Brunt of Rising Gas Prices Nvidia Beats Expectations as AI Boom Drives 85 Revenue Surge Yet Shares Dip on Competitive Concerns Coal India Plans Syngas Projects to Offset Tightening Gas Supply for Power and Fertilizer Sectors PayWhatYouWant Model Gains Traction as Diners Tighten Spending Fed Dissenters Object to Rate Cut Signal Citing Uncertainty Over Next Move BY Q1 2026 Earnings EPS Beats Estimates by 755 Stock Slightly Down AFRM Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction WHLRD Q2 2024 Earnings Limited Data Preferred Stock Reports EPS of 365 CMSA Q1 2026 Earnings EPS Beats Estimates Amid Stable Utility Operations NexGen Energy NXE Q1 2026 Earnings Substantial EPS Miss Highlights PreRevenue Development Phase PACB Q1 2026 Earnings Loss Narrower Than Expected Stock Declines 24 ReTo EcoSolutions RETO Faces Sharp Decline Testing Key Support Levels Globa Terra Acquisition Corporation Rights GTERR Trades Steady Near Support at 010 Voya Infrastructure Industrials and Materials Fund IDE Faces Selling Pressure as Shares Slide Over 1 Professional Diversity Network IPDN Gains 2 as Stock Nears Key Resistance Level Iron Horse Acquisitions Corp II Rights IRHOR Edges Higher Amid Speculative Trading SpaceX IPO Opens Door for Retail Traders via Major Brokerage Platforms MTVA Q1 2026 Earnings EPS Misses Estimates but Stock Surges 3415 Saba Capital Income Opportunities Fund II SABA Edges Lower Amid Modest Trading Activity Jaguar Health JAGX Drops 12 Navigating Key Support Near 29 Vir Biotechnology VIR Rallies 495 Key Levels to Watch After Move to 955 Entergy New Orleans Bonds ENO Edge Higher at 218 Holding Above Key Support Yunji Inc YJ Slides 774 Amid Selling Pressure Approaches Key Support MFS Charter Income Trust MCR Holds Steady Near Support Amid Modest Gains Lamar Advertising LAMR Edges Higher as Billboard REIT Tests Key Support Zone Protalix BioTherapeutics PLX Rises 143 as Biotech Stock Tests Key Resistance